These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 35617302

  • 21. Atypical Hemolytic Uremic Syndrome after ChAdOx1 nCoV-19 Vaccination in a Patient with Homozygous CFHR3/CFHR1 Gene Deletion.
    Ferrer F, Roldão M, Figueiredo C, Lopes K.
    Nephron; 2022; 146(2):185-189. PubMed ID: 34724668
    [Abstract] [Full Text] [Related]

  • 22. An Infant Case of Streptococcus Pneumoniae-Associated Thrombotic Microangiopathy with Heterozygous CFI Mutation and CFHR3-CFHR1 Deletion.
    Matsumoto Y, Ikezumi Y, Kondoh T, Yokoi K, Nakajima Y, Kumagai N, Kato T, Kurahashi H, Ito T.
    Tohoku J Exp Med; 2022 Oct 25; 258(3):183-193. PubMed ID: 36070894
    [Abstract] [Full Text] [Related]

  • 23. Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.
    Hofer J, Janecke AR, Zimmerhackl LB, Riedl M, Rosales A, Giner T, Cortina G, Haindl CJ, Petzelberger B, Pawlik M, Jeller V, Vester U, Gadner B, van Husen M, Moritz ML, Würzner R, Jungraithmayr T, German-Austrian HUS Study Group.
    Clin J Am Soc Nephrol; 2013 Mar 25; 8(3):407-15. PubMed ID: 23243267
    [Abstract] [Full Text] [Related]

  • 24. Favorable four-yr outcome after renal transplantation in a patient with complement factor H antibody and CFHR1/CFHR3 gene mutation-associated HUS.
    Grenda R, Jarmużek W, Rubik J, Prokurat S, Miklaszewska M, Drozdz D, Zachwieja K, Ardissino G, Hofer J.
    Pediatr Transplant; 2015 Sep 25; 19(6):E130-4. PubMed ID: 26087050
    [Abstract] [Full Text] [Related]

  • 25. A novel hybrid CFHR1/CFH gene causes atypical hemolytic uremic syndrome.
    Eyler SJ, Meyer NC, Zhang Y, Xiao X, Nester CM, Smith RJ.
    Pediatr Nephrol; 2013 Nov 25; 28(11):2221-5. PubMed ID: 23880784
    [Abstract] [Full Text] [Related]

  • 26. Atypical haemolytic uremic syndrome with refractory multiorgan involvement and heterozygous CFHR1/CFHR3 gene deletion.
    Diep J, Potter D, Mai J, Hsu D.
    BMC Nephrol; 2023 May 05; 24(1):127. PubMed ID: 37147581
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Unraveling Structural Rearrangements of the CFH Gene Cluster in Atypical Hemolytic Uremic Syndrome Patients Using Molecular Combing and Long-Fragment Targeted Sequencing.
    Tschernoster N, Erger F, Walsh PR, McNicholas B, Fistrek M, Habbig S, Schumacher AL, Folz-Donahue K, Kukat C, Toliat MR, Becker C, Thiele H, Kavanagh D, Nürnberg P, Beck BB, Altmüller J.
    J Mol Diagn; 2022 Jun 05; 24(6):619-631. PubMed ID: 35398599
    [Abstract] [Full Text] [Related]

  • 29. The major autoantibody epitope on factor H in atypical hemolytic uremic syndrome is structurally different from its homologous site in factor H-related protein 1, supporting a novel model for induction of autoimmunity in this disease.
    Bhattacharjee A, Reuter S, Trojnár E, Kolodziejczyk R, Seeberger H, Hyvärinen S, Uzonyi B, Szilágyi Á, Prohászka Z, Goldman A, Józsi M, Jokiranta TS.
    J Biol Chem; 2015 Apr 10; 290(15):9500-10. PubMed ID: 25659429
    [Abstract] [Full Text] [Related]

  • 30. The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome.
    Dragon-Durey MA, Blanc C, Marliot F, Loirat C, Blouin J, Sautes-Fridman C, Fridman WH, Frémeaux-Bacchi V.
    J Med Genet; 2009 Jul 10; 46(7):447-50. PubMed ID: 19435718
    [Abstract] [Full Text] [Related]

  • 31. CFHR Gene Variations Provide Insights in the Pathogenesis of the Kidney Diseases Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.
    Zipfel PF, Wiech T, Stea ED, Skerka C.
    J Am Soc Nephrol; 2020 Feb 10; 31(2):241-256. PubMed ID: 31980588
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Analysis of variants in complement genes in Han Chinese children with atypical hemolytic uremic syndrome].
    Yi CL, Zhao F, Qiu HZ, Wang LM, Huang J, Nie XJ, Yu ZH.
    Zhonghua Er Ke Za Zhi; 2017 Aug 02; 55(8):624-627. PubMed ID: 28822440
    [Abstract] [Full Text] [Related]

  • 36. Successful 7-Year Eculizumab Treatment of Plasmapheresis-Resistant Recurrent Atypical Hemolytic-Uremic Syndrome due to Complement Factor H Hybrid Gene: A Case Report.
    Vondrák K, Seeman T.
    Transplant Proc; 2018 Apr 02; 50(3):967-970. PubMed ID: 29661469
    [Abstract] [Full Text] [Related]

  • 37. Complement Genetic Variants and FH Desialylation in S. pneumoniae-Haemolytic Uraemic Syndrome.
    Gómez Delgado I, Corvillo F, Nozal P, Arjona E, Madrid Á, Melgosa M, Bravo J, Szilágyi Á, Csuka D, Veszeli N, Prohászka Z, Sánchez-Corral P.
    Front Immunol; 2021 Apr 02; 12():641656. PubMed ID: 33777036
    [Abstract] [Full Text] [Related]

  • 38. Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review.
    de Holanda MI, Pôrto LC, Wagner T, Christiani LF, Palma LMP.
    Clin Rheumatol; 2017 Dec 02; 36(12):2859-2867. PubMed ID: 28905254
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.